Teresa Caballero Velázquez
Teresa Caballero Velázquez
Profesor Contratado Doctor (Plaza Vinc.)
Verified email at
Cited by
Cited by
Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting
LI Sánchez-Abarca, S Gutierrez-Cosio, C Santamaría, ...
Blood, The Journal of the American Society of Hematology 115 (1), 107-121, 2010
Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease
F Sánchez-Guijo, T Caballero-Velázquez, O López-Villar, A Redondo, ...
Biology of Blood and Marrow Transplantation 20 (10), 1580-1585, 2014
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
V Escamilla Gómez, V García-Gutiérrez, L López Corral, ...
Bone marrow transplantation 55 (3), 641-648, 2020
Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population
B Blanco, JA Pérez-Simón, LI Sánchez-Abarca, T Caballero-Velazquez, ...
haematologica 94 (7), 975, 2009
Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma
B Paiva, M Chandia, MB Vidriales, E Colado, T Caballero-Velázquez, ...
Blood, The Journal of the American Society of Hematology 124 (8), 1300-1303, 2014
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post‐allogeneic transplantation for high‐risk myeloma patients
T Caballero‐Velázquez, L López‐Corral, C Encinas, C Castilla‐Llorente, ...
British journal of haematology 162 (4), 474-482, 2013
Immunomodulatory effect of vitamin D after allogeneic stem cell transplantation: results of a prospective multicenter clinical trial
T Caballero-Velázquez, I Montero, F Sánchez-Guijo, R Parody, ...
Clinical Cancer Research 22 (23), 5673-5681, 2016
Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens
B Blanco, LI Sánchez-Abarca, T Caballero-Velázquez, C Santamaría, ...
Leukemia research 35 (10), 1412-1415, 2011
Sensitivity of hematopoietic stem cells to mitochondrial dysfunction by SdhD gene deletion
JA Bejarano-García, Á Millán-Uclés, IV Rosado, LI Sánchez-Abarca, ...
Cell Death & Disease 7 (12), e2516-e2516, 2016
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia
B Paiva, MB Vidriales, A Sempere, F Tarín, E Colado, C Benavente, ...
Leukemia 35 (8), 2358-2370, 2021
Limbus damage in ocular graft-versus-host disease
RL Pérez, JA Pérez-Simón, T Caballero-Velazquez, T Flores, S Carrancio, ...
Biology of Blood and Marrow Transplantation 17 (2), 270-273, 2011
Cannabinoid derivatives exert a potent anti‐myeloma activity both in vitro and in vivo
MV Barbado, M Medrano, T Caballero‐Velázquez, I Álvarez‐Laderas, ...
International Journal of Cancer 140 (3), 674-685, 2017
Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment
S Gutierrez-Cosio, L de la Rica, E Ballestar, C Santamaría, ...
Leukemia research 36 (7), 895-899, 2012
Effect of vitamin D treatment in chronic GVHD
F Silva, JA Pérez-Simón, T Caballero-Velázquez, FM Sánchez-Guijo, ...
Bone marrow transplantation 46 (10), 1395-1397, 2011
The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation
T Caballero-Velázquez, LI Sánchez-Abarca, S Gutierrez-Cosio, B Blanco, ...
haematologica 97 (9), 1329, 2012
Human bone marrow stromal cells differentiate into corneal tissue and prevent ocular graft-versus-host disease in mice
LI Sánchez-Abarca, E Hernández-Galilea, R Lorenzo, C Herrero, ...
Cell transplantation 24 (12), 2423-2433, 2015
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
G Afram, JAP Simón, M Remberger, T Caballero-Velázquez, R Martino, ...
Medical Oncology 35, 1-8, 2018
Evaluation of prognostic factors among patients with chronic graft-versus-host disease
JA Pérez-Simón, G Afram, R Martino, JL Piñana, T Caballero-Velazquez, ...
haematologica 97 (8), 1187, 2012
Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease
FN Villanueva, JA Pérez-Simón, FF Silva, TT Caballero-Velázquez, ...
Biology of Blood and Marrow Transplantation 15 (10), 1331-1336, 2009
Uptake and delivery of antigens by mesenchymal stromal cells
LI Sánchez-Abarca, I Álvarez-Laderas, MD Campelo, ...
Cytotherapy 15 (6), 673-678, 2013
The system can't perform the operation now. Try again later.
Articles 1–20